[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581002":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":29,"collaborators":7,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":7,"enrollmentInfo":42,"targetDuration":7,"studyType":45,"phases":7,"briefSummary":46,"conditions":47,"keywords":7,"overallStatus":16,"whyStopped":7,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":59},{"fullName":5,"class":6},"China-Japan Friendship Hospital","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"weiping kong","CONTACT","0086-10-13611038252","kongweiping75@126.com",[15],{"facility":5,"status":16,"city":17,"state":7,"zip":7,"country":18,"countryCode":19,"cosmosGeoPoint":20,"geoPoint":25,"contacts":26},"RECRUITING","Beijing","China","CN",{"type":21,"coordinates":22},"Point",[23,24],116.39723,39.9075,{"lat":24,"lon":23},[27],{"name":28,"role":11,"phone":12,"phoneExt":7,"email":13},"wei Kong, Docotr",{"type":30,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Weiping Kong","Professor","100581002","the-disease-progression-of-chinese-axial-spondyloarthritis-in-a-real-word-cohort-study-100581002",false,"NCT06844643","The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study","DPCASPA","Inclusion Criteria:\n\n* Patients aged 18 years or older\n* Diagnosis of axial spondyloarthritis (axSpA) according to the Assessment of Spondyloarthritis International Society (ASAS) classification criteria\n\nExclusion Criteria:\n\n* Presence of severe, unstable medical conditions that may interfere with the study assessments, including but not limited to:\n\nEnd-stage renal disease (eGFR \\\u003C 30 mL\u002Fmin\u002F1.73m²) Severe cardiovascular disease Active malignancy or malignancy requiring ongoing treatment\n\n* Current diagnosis of schizophrenia, other psychotic disorders, severe cognitive impairment, or epilepsy with recurrent uncontrolled seizures, which, in the opinion of the investigator, may impair the ability to provide informed consent or comply with follow-up visits.\n* Pregnant or lactating women","ALL","18 Years",{"count":43,"type":44},2250,"ESTIMATED","OBSERVATIONAL","An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.",[48,49],"Axial Spondyloarthritis","Ankylosing Spondylitis (AS)","2026-04-10",{"date":52,"type":53},"2026-04-13","ACTUAL",{"date":55,"type":53},"2025-03-01",{"date":57,"type":44},"2030-12-01",{"name":5,"class":6},1]